✦ LIBER ✦

Primary hepatic malignant lymphoma: Its occurrence in a patient with chronic active hepatitis, cirrhosis, and hepatocellular carcinoma associated with hepatitis B viral infection

✍ Scribed by Thomas S. Talamo; Andrew Dekker; John Gurecki; Gurmukh Singh

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 764 KB
Volume: 46
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19800715)46:2<336::aid-cncr2820460221>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Occult hepatitis B virus infection is as

Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients

✍ Giovanni Squadrito; Teresa Pollicino; Irene Cacciola; Gaia Caccamo; Daniela Vill 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Dysplastic nodules frequently develop in

Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis

✍ Masahiro Kobayashi; Kenji Ikeda; Tetsuya Hosaka; Hitomi Sezaki; Takashi Someya; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Occult and previous hepatitis B virus in

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

✍ Anna S. Lok; James E. Everhart; Adrian M. Di Bisceglie; Hae-Young Kim; Munira Hu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

Previous studies have suggested that prior exposure to hepatitis B virus (HBV) infection may increase the risk of development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. The aim of this study was to compare the prevalence of previous or occult HBV infection in a cohort of

Association of concurrent hepatitis B su

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

Can interferon alfa treatment prevent he

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

✍ S E Harper; J L Dienstag 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

Clearance of hepatitis B surface antigen

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

✍ Josephine Simonetti; Lisa Bulkow; Brian J. McMahon; Chriss Homan; Mary Snowball; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC